| Dr Dallas Justin Patterson, DPM | |
|
423 Treeline Park, Suite #315, San Antonio, TX 78209-2060 | |
| (210) 614-9610 | |
| (210) 614-9613 |
| Full Name | Dr Dallas Justin Patterson |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 12 Years |
| Location | 423 Treeline Park, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083912323 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 1998 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jerry W. Patterson Dpm Pa | 6901052042 | 2 |
| The Weston Group Inc | 8123936796 | 301 |
News Archive
New research has shown how a cell surface molecule, Lymphotoxin β receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant are slow to recover their immune system.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official change of its name to the Cell and Gene Therapy Catapult.
An international team of scientists has announced a new advance in the ability to target and destroy certain cancer cells. A group led by the University of Leicester has shown that particular cancer cells are especially sensitive to a protein called p21. This protein usually forces normal and cancer cells to stop dividing but it was recently shown that in some cases it can also kill cancer cells.
Understanding how RNA binding proteins control the genetic splicing code is fundamental to human biology and disease - much like editing film can change a movie scene. Abnormal variations in splicing are often implicated in cancer and genetic neurodegenerative disorders.
Using a $225,000 microscope, researchers have identified the key components of a protein called TRIM5α that destroys HIV in rhesus monkeys.The finding could lead to new TRIM5α-based treatments that would knock out HIV in humans, said senior researcher Edward M. Campbell, PhD, of Loyola University Health System.
› Verified 1 days ago
| Provider Name | Jerry W. Patterson Dpm Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326308305 PECOS PAC ID: 6901052042 Enrollment ID: O20120806000818 |
News Archive
New research has shown how a cell surface molecule, Lymphotoxin β receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant are slow to recover their immune system.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official change of its name to the Cell and Gene Therapy Catapult.
An international team of scientists has announced a new advance in the ability to target and destroy certain cancer cells. A group led by the University of Leicester has shown that particular cancer cells are especially sensitive to a protein called p21. This protein usually forces normal and cancer cells to stop dividing but it was recently shown that in some cases it can also kill cancer cells.
Understanding how RNA binding proteins control the genetic splicing code is fundamental to human biology and disease - much like editing film can change a movie scene. Abnormal variations in splicing are often implicated in cancer and genetic neurodegenerative disorders.
Using a $225,000 microscope, researchers have identified the key components of a protein called TRIM5α that destroys HIV in rhesus monkeys.The finding could lead to new TRIM5α-based treatments that would knock out HIV in humans, said senior researcher Edward M. Campbell, PhD, of Loyola University Health System.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dallas Justin Patterson, DPM 423 Treeline Park, Suite #315, San Antonio, TX 78209-2060 Ph: (210) 614-9610 | Dr Dallas Justin Patterson, DPM 423 Treeline Park, Suite #315, San Antonio, TX 78209-2060 Ph: (210) 614-9610 |
News Archive
New research has shown how a cell surface molecule, Lymphotoxin β receptor, controls entry of T-cells into the thymus; and as such presents an opportunity to understanding why cancer patients who undergo bone-marrow transplant are slow to recover their immune system.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official change of its name to the Cell and Gene Therapy Catapult.
An international team of scientists has announced a new advance in the ability to target and destroy certain cancer cells. A group led by the University of Leicester has shown that particular cancer cells are especially sensitive to a protein called p21. This protein usually forces normal and cancer cells to stop dividing but it was recently shown that in some cases it can also kill cancer cells.
Understanding how RNA binding proteins control the genetic splicing code is fundamental to human biology and disease - much like editing film can change a movie scene. Abnormal variations in splicing are often implicated in cancer and genetic neurodegenerative disorders.
Using a $225,000 microscope, researchers have identified the key components of a protein called TRIM5α that destroys HIV in rhesus monkeys.The finding could lead to new TRIM5α-based treatments that would knock out HIV in humans, said senior researcher Edward M. Campbell, PhD, of Loyola University Health System.
› Verified 1 days ago
Thomas Zgonis, D.P.M. Podiatrist Medicare: Medicare Enrolled Practice Location: 7726 Louis Pasteur Dr, San Antonio, TX 78229 Phone: 210-575-3327 Fax: 210-575-7699 | |
Michael Lee Dempsey, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7500 Barlite Blvd, Suite 311, San Antonio, TX 78224 Phone: 210-572-9255 Fax: 210-572-9256 | |
Del Rio Foot Clinic P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 94 Briggs St Ste 600, San Antonio, TX 78224 Phone: 210-872-3668 Fax: 210-428-6317 | |
South Texas Foot Surgeons, P.a. Podiatrist Medicare: Medicare Enrolled Practice Location: 5282 Medical Dr, Suite 260, San Antonio, TX 78229 Phone: 210-616-0819 Fax: 210-692-9529 | |
Mohammad-asad Buksh Ilahi, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 701 S Zarzamora St, San Antonio, TX 78207 Phone: 210-358-7402 | |
Dr. Evan F. Meltzer, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 7400 Merton Minter St, Audie L. Murphy Vamc, San Antonio, TX 78229 Phone: 210-617-5300 | |
Kris A Ford, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 102 Palo Alto Rd, Suite 133, San Antonio, TX 78211 Phone: 210-923-9200 Fax: 210-923-9202 |